Deutsche Bank Maintains Sell on AstraZeneca (AZN)
AstraZeneca PLC (NYSE:AZN) is one of the 10 Top Stocks Fund Managers Are Loading Up On in 2026. Deutsche Bank Maintains Sell on AstraZeneca (AZN) On March 27, 2026, Deutsche Bank maintained a Sell rating on AstraZeneca PLC (NYSE:AZN). The firm’s analyst kept a price target of £115 on the stock. On the other hand, in a more recent update, Guggenheim raised the firm’s price target on AstraZeneca PLC (NYSE:AZN) from 16,000 GBp to 16,500 GBp. Analyst Seamus Fernandez kept a Buy rating on the company’s stock. ...